Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Cardiovascular Toxicity of Molecular Targeted Therapy in Cancer Patients: A Double-Edged Sword.

Liu KL, Chen JS, Chen SC, Chu PH.

Acta Cardiol Sin. 2013 Jul;29(4):295-303. Review.

2.

Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer.

Yu AF, Manrique C, Pun S, Liu JE, Mara E, Fleisher M, Patil S, Jones LW, Steingart RM, Hudis CA, Dang CT.

Oncologist. 2016 Apr;21(4):418-24. doi: 10.1634/theoncologist.2015-0321. Epub 2016 Mar 16.

PMID:
26984450
3.

Cardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic training.

Scott JM, Armenian S, Giralt S, Moslehi J, Wang T, Jones LW.

Crit Rev Oncol Hematol. 2016 Feb;98:222-34. doi: 10.1016/j.critrevonc.2015.11.007. Epub 2015 Nov 17. Review.

PMID:
26643524
4.

Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs.

Molinaro M, Ameri P, Marone G, Petretta M, Abete P, Di Lisa F, De Placido S, Bonaduce D, Tocchetti CG.

Biomed Res Int. 2015;2015:138148. doi: 10.1155/2015/138148. Epub 2015 Oct 25. Review.

5.

Diagnostic accuracy of left ventricular longitudinal function by speckle tracking echocardiography to predict significant coronary artery stenosis. A systematic review.

Norum IB, Ruddox V, Edvardsen T, Otterstad JE.

BMC Med Imaging. 2015 Jul 25;15:25. doi: 10.1186/s12880-015-0067-y. Review.

6.

Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA).

Reuvekamp EJ, Bulten BF, Nieuwenhuis AA, Meekes MR, de Haan AF, Tol J, Maas AH, Elias-Smale SE, de Geus-Oei LF.

J Nucl Cardiol. 2016 Aug;23(4):824-32. doi: 10.1007/s12350-015-0164-x. Epub 2015 Jun 6.

7.

Noninvasive assessment of myocardial mechanics of the left ventricle in rabbits using velocity vector imaging.

Zhou J, Pu DR, Tian LQ, Tong H, Liu HY, Tang Y, Zhou QC.

Med Sci Monit Basic Res. 2015 May 28;21:109-15. doi: 10.12659/MSMBR.894053.

8.

Evaluation of Right Ventricular Myocardial Mechanics Using Velocity Vector Imaging of Cardiac MRI Cine Images in Transposition of the Great Arteries Following Atrial and Arterial Switch Operations.

Thattaliyath BD, Forsha DE, Stewart C, Barker PC, Campbell MJ.

Congenit Heart Dis. 2015 Jul-Aug;10(4):371-9. doi: 10.1111/chd.12250. Epub 2015 Feb 5.

9.

Cardiac risk in the treatment of breast cancer: assessment and management.

Valachis A, Nilsson C.

Breast Cancer (Dove Med Press). 2015 Jan 16;7:21-35. doi: 10.2147/BCTT.S47227. eCollection 2015. Review.

10.

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, Ganame J, Sebag IA, Agler DA, Badano LP, Banchs J, Cardinale D, Carver J, Cerqueira M, DeCara JM, Edvardsen T, Flamm SD, Force T, Griffin BP, Jerusalem G, Liu JE, Magalhães A, Marwick T, Sanchez LY, Sicari R, Villarraga HR, Lancellotti P.

Eur Heart J Cardiovasc Imaging. 2014 Oct;15(10):1063-93. doi: 10.1093/ehjci/jeu192. No abstract available.

11.

Cancer and cardiovascular disease: the use of novel echocardiography measures to predict subsequent cardiotoxicity in breast cancer treated with anthracyclines and trastuzumab.

Gulati G, Zhang KW, Scherrer-Crosbie M, Ky B.

Curr Heart Fail Rep. 2014 Dec;11(4):366-73. doi: 10.1007/s11897-014-0214-8. Review.

12.

Risk prediction model for heart failure and cardiomyopathy after adjuvant trastuzumab therapy for breast cancer.

Ezaz G, Long JB, Gross CP, Chen J.

J Am Heart Assoc. 2014 Feb 28;3(1):e000472. doi: 10.1161/JAHA.113.000472.

13.

Cardiac complications of chemotherapy: role of imaging.

Tan TC, Scherrer-Crosbie M.

Curr Treat Options Cardiovasc Med. 2014 Apr;16(4):296. doi: 10.1007/s11936-014-0296-3.

14.

Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy.

Khouri MG, Hornsby WE, Risum N, Velazquez EJ, Thomas S, Lane A, Scott JM, Koelwyn GJ, Herndon JE, Mackey JR, Douglas PS, Jones LW.

Breast Cancer Res Treat. 2014 Feb;143(3):531-9. doi: 10.1007/s10549-013-2818-1. Epub 2014 Jan 4.

15.

Chemotherapy-induced Cardiotoxicity.

Florescu M, Cinteza M, Vinereanu D.

Maedica (Buchar). 2013 Mar;8(1):59-67.

16.

Echocardiography in the era of multimodality cardiovascular imaging.

Shah BN.

Biomed Res Int. 2013;2013:310483. doi: 10.1155/2013/310483. Epub 2013 Jun 26. Review.

17.

Assessing the Cardiac Toxicity of Chemotherapeutic Agents: Role of Echocardiography.

Tan TC, Scherrer-Crosbie M.

Curr Cardiovasc Imaging Rep. 2012 Dec 1;5(6):403-409.

18.

Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues.

Khouri MG, Douglas PS, Mackey JR, Martin M, Scott JM, Scherrer-Crosbie M, Jones LW.

Circulation. 2012 Dec 4;126(23):2749-63. doi: 10.1161/CIRCULATIONAHA.112.100560. Review. No abstract available.

19.

Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab.

Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Tan TC, Cohen V, Banchs J, Carver JR, Wiegers SE, Martin RP, Picard MH, Gerszten RE, Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M.

Circ Cardiovasc Imaging. 2012 Sep 1;5(5):596-603. Epub 2012 Jun 28.

20.

Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs.

Jiji RS, Kramer CM, Salerno M.

J Nucl Cardiol. 2012 Apr;19(2):377-88. doi: 10.1007/s12350-012-9512-2. Review.

Items per page

Supplemental Content

Write to the Help Desk